Abstract
Recent evidence suggests that the intestine may play a direct facilitative role in reverse cholesterol transport (RCT), independent of hepatobiliary secretion. In order to understand the nonbiliary pathway for RCT, we created both genetic and surgical models of biliary cholesterol insufficiency. To genetically inhibit biliary cholesterol secretion, we generated mice in which Niemann-Pick C1-Like 1 (NPC1L1) was overexpressed in the liver. Compared to controls, NPC1L1Liver-Tg mice exhibit a >90% decrease in biliary cholesterol secretion, yet mass fecal sterol loss and macrophage RCT are normal. To surgically inhibit biliary emptying into the intestine, we have established an acute biliary diversion model. Strikingly, macrophage RCT persists in mice surgically lacking the ability to secrete bile into the intestine. Collectively, these studies demonstrate that mass fecal sterol loss and macrophage RCT can proceed in the absence of biliary sterol secretion, challenging the obligate role of bile in RCT.
Original language | English |
---|---|
Pages (from-to) | 96-102 |
Number of pages | 7 |
Journal | Cell Metabolism |
Volume | 12 |
Issue number | 1 |
DOIs | |
State | Published - Jul 7 2010 |
Bibliographical note
Funding Information:We sincerely thank Paul Dawson (Wake Forest University) for critical reading of this manuscript and providing meaningful input into these studies. We also thank George Rothblat (The Children's Hospital of Philadelphia) for providing J774 macrophages. This work was supported by the National Heart, Lung, and Blood Institute through a pathway to independence grant (1K99-HL096166 to J.M.B.) and a program project grant (5P01HL049373 to L.L.R.). L.Y. is supported by a Scientist Development Grant (#0635261N) from the American Heart Association. L.L.R. is a member of the Merck speaker's bureau.
Keywords
- HUMDISEASE
ASJC Scopus subject areas
- Physiology
- Molecular Biology
- Cell Biology